Notes on Jewelweed and Poison Ivy Dermatitis Study

Ethnopharmacological relevance and study aim

• Jewelweed refers to Impatiens capensis (jewelweed) and its relative Impatiens balsamina (garden balsam).
• Traditional/ethnobotanical use:
  • Native American tribes historically used I. capensis and related plants to treat and prevent rashes from plant sources, notably poison ivy (Toxicodendron radicans) and stinging nettles.
  • Cherokee, Potawatomi, Chippewa, Meskwaki, and Omaha peoples used fresh juice or plant parts to treat PI rash and nettle stings; some practices involved rubbing jewelweed on the skin before exposure or soon after contact.
  • In East Asia, Impatiens spp. extracts are used in traditional medicine for itching, pain, swelling, and antimicrobial purposes.
  • Commercial jewelweed products (soaps, sprays, creams) market themselves as preventives for poison ivy dermatitis.
• Toxicological background:
  • Poison ivy dermatitis is due to urushiol, a mixture of catechols produced by Toxicodendron radicans; urushiol sensitization affects roughly 50–70% of the population.
  • Sensitivity varies: symptoms can start within ~4 hours to ~10 days after exposure and range from redness to vesiculation and weeping.
  • Some studies suggested jewelweed could reduce dermatitis; others reported no effect or only itch relief; results have been inconsistent across methods and exposure paradigms.
• Aim of this study:
  • Validate ethnopharmacological use of jewelweed for the prevention of poison ivy dermatitis, using realistic exposure models.
  • Compare native I. capensis vs. introduced I. balsamina and measure lawsone content to see if lawsone correlates with efficacy.
  • Test plant-derived preparations (fresh mash, aqueous and oil extracts) and soaps derived from jewelweed to assess their prophylactic effects.
  • Determine whether any observed efficacy aligns with lawsone content or suggests other active components (e.g., saponins).

Compounds and plant constituents

• Lawsone (2-hydroxy-1,4-naphthoquinone): a key compound identified in jewelweed; associated with antimicrobial, antioxidant, and immunomodulatory properties; reported to inhibit COX-2 and proposed to compete with urushiol at a similar binding site in some hypotheses.
  • Structural representation: ext{Lawsone structure: } \ce{!!!!! (see Fig. 1 in paper) }
  • Reported content varies with plant part, harvest time, and extraction method.
• Other constituents reported in jewelweed and related Impatiens spp.:
  • Kaempferol and quercetin (flavonols) in jewelweed flowers.
  • Phenolics, flavonols, anthocyanins, quinones, saponins in aerial parts.
  • Impatienol (a secondary metabolite) in Impatiens species.
  • Antimicrobial peptides and saponins in seeds (Impatiens capensis and balsamina).
• The study considers whether lawsone concentration correlates with protective efficacy; other components (e.g., saponins) may mediate soap-like activity.

Research design and hypotheses

• Hypotheses:
  • Jewelweed plant material (especially fresh mash) reduces PI dermatitis after exposure to urushiol-containing plant material.
  • Jewelweed extracts and soaps may reduce dermatitis, but the magnitude of effect may depend on lawsone content.
  • If lawsone is the primary active agent, higher lawsone content should correlate with greater protection; if not, alternative components (e.g., saponins) or physical washing effects may predominate.
• Realism in exposure model:
  • A more realistic PI exposure protocol was used: PI leaves brushed onto forearms, then areas treated with test substances, followed by a standardized exposure and 48-hour bandage.
  • Six treatment protocols were studied across two subject groups with N = 25 (protocol 1) and N = 15 (protocol 2).

Methods: materials, preparations, and analysis

• Plant materials and preparations:
  • Fresh plant material and extracts used: I. capensis and I. balsamina (fresh mash, aqueous infusions, and olive oil infusions).
  • Soap preparation: infusions (60 g NaOH with 150 mL aqueous infusion) combined with warmed grapeseed oil and coconut oil, then infused with additional plant-infused olive oil to yield jewelweed soaps.
  • Distillation and analysis: steam distillate of I. capensis; reversed-phase HPLC with UV–vis detection for lawsone quantification.
• HPLC details for lawsone quantification:
  • Instrument: Agilent 1100 with UV–vis diode array detector; detection wavelength: $\lambda = 278\,\text{nm}$
  • Column: Zorbax Eclipse Plus C18, $2.1\times 50\text{ mm}^2, 3.5\mu\text{m}$
  • Mobile phase: isocratic $25\%\text{ methanol} + 75\% 0.1\,\text{M acetic acid}$
  • Flow rate: $0.500\,\text{mL/min}$; injection volume: $10\,\mu\text{L}$
• Preparation of fresh plant mash and infusions:
  • Mash: chopped fresh plants blended to a stringy, thick pulp.
  • Aqueous infusion: 250 g fresh plant pulp + 500 mL distilled water; infused for one week.
  • Olive oil infusion: 250 g fresh plant pulp + 500 mL olive oil; infused for one week.
  • Filtration: infusions filtered for use in soap preparation.
• Soap preparation details:
  • Aqueous infusion's active constituents were combined with NaOH and warmed oils to form a soap mixture; to reach a 'trace' (soap state indicating saponification and emulsification) after mixing.
  • Final soap included 150 mL of plant-infused aqueous extract into oil-based base to yield bars after 48 hours hardening.
• Exposure and scoring protocol:
  • Participants: 40 volunteers (18–65 years old) with forearms free of prior inflammation.
  • Exposure setup: three 2 cm × 2 cm squares per forearm were marked; PI leaves rubbed onto a grater to ensure urushiol exposure; areas exposed by rubbing the ivy onto the marked squares.
  • Protocols:
  • Protocol 1 (N = 25): (1) single water wash, (2) double water wash, (3) I. capensis mash, (4) I. capensis aqueous infusion, (5) lawsone solution (154.5 mg/mL equivalent to fresh I. capensis extract), (6) jewelweed soap.
  • Protocol 2 (N = 15): (1) single water wash, (2) I. balsamina extract, (3) I. balsamina mash, (4) I. balsamina soap, (5) I. capensis soap, (6) Dawns dish soap.
  • Application: each treatment applied with saturated cotton-tipped applicators; 5 strokes perpendicular to PI application; areas bandaged for 48 h.
  • Scoring: rash development scored on a 0–14 scale (Table 1) at specified times: Protocol 1 (24, 48, 96 h, and 7 days); Protocol 2 (96 h, 7 days, 10 days).
• Outcome measures and analyses:
  • Primary outcome: rash development score (0–14).
  • Secondary outcomes: presence and magnitude of rash, and Lawsone content in various preparations.
  • Statistical analyses: ANOVA to test differences between treatments; paired t-tests against their own controls; 95% confidence interval for effectiveness of jewelweed mash in reducing rash; assessment of significance markers in figures.
• Key reference framework and comparators:
  • Comparators included water wash, Dawns dish soap, and lawsone standard solution adjusted to the concentration found in I. capensis infusion.
  • The study attempted to mimic traditional use (plant mash) and modern products (soaps) as potential prophylactics against PI dermatitis.

Key results: lawsone content and formulation efficacy

• Lawsone content across preparations (measured by HPLC, mg lawsone per g plant material):
  • I. capensis mash harvested toward end of growing season: $213\ \text{mg/g}$
  • Roots and aerial parts (hypocotyls and epicotyls) of I. capensis: $381\ \text{mg/g}$
  • I. balsamina mash (midseason): $744\ \text{mg/g}$
  • I. balsamina mash (end of season): $84\ \text{mg/g}$
  • Fresh aqueous infusions: I. capensis $750\ \text{mg/g}$; I. balsamina $745\ \text{mg/g}$
  • Freezing or drying or extraction with alcohol/olive oil greatly reduces lawsone yield.
  • Soap preparations contained: I. capensis soap $113\ \text{mg/g}$; I. balsamina soap $111\ \text{mg/g}$
• Dermatitis outcomes and treatment efficacy (rash scores, 0–14 scale):
  • Overall, about half of participants did not develop significant dermatitis.
  • Protocol 1: rash developed in 15 of 25 participants.
  • Protocol 2: rash developed in 7 of 15 participants.
  • Median rash score across those who developed rash: $10$ (Protocol 1).
  • Comparisons to control (water only): control average rash score ≈ $9.3$.
  • Jewelweed extracts (I. capensis and I. balsamina) averaged rash score: $6.7$ (71.5% of control).
  • Lawsone solution rash score: $7.0$ (not significantly different from control).
  • Plant mash treatments: average rash score ≈ $4.7$.
  • Jewelweed soaps: average rash score ≈ $3.1$.
  • Statistical interpretation:
  • ANOVA rejected the null hypothesis that there were no differences between treatment groups.
  • Pairwise comparisons vs own controls showed:
    • I. capensis and I. balsamina extracts: not significantly different from water control overall, but mash showed a notable reduction.
    • I. balsamina mash vs control: significant (reached about 50% of control rash).
    • I. capensis soap, I. balsamina soap, and Dawns dish soap: none significantly different from control for rash magnitude, but each had lower mean scores (3.1) than control, with soaps performing similarly to each other.
• Key interpretation of the results:
  • Jewelweed mash is effective in decreasing the development of urushiol-induced dermatitis, with a 95% confidence interval suggesting a protective effect when compared to water control.
  • The protective effect of jewelweed soaps is not due to lawsone content, since soaps with similar lawsone content did not outperform Dawns dish soap; instead, the amphipathic (soap-like) properties likely bind and remove urushiol.
  • The overall efficacy of the plant mash and soaps is not tightly correlated with lawsone content, suggesting other constituents (e.g., saponins, water content, mechanical scrubbing) play major roles.
  • The timing and mode of exposure influence outcomes; some prior studies exposing participants for longer durations (e.g., 15 minutes) may have overwhelmed any prophylactic effect from jewelweed.

Mechanisms, interpretations, and implications

• Proposed mechanisms for safety and efficacy:
  • Soaps (amphipathic molecules) can bind and solubilize urushiol, aiding its removal from skin; this effect appears independent of lawsone content in the tested preparations.
  • Fresh plant mash likely acts mainly via water content and saponins that facilitate urushiol removal during washing and provide mild abrasive scrubbing, enhancing clean-off action.
  • Harvest time influences lawsone content; midseason harvest yielded higher lawsone levels than end-season harvest, which could contribute to inconsistent results across studies and samples if lawsone is the primary active agent.
  • The authors hypothesize that saponins may be the key active agents in jewelweed soaps, consistent with the soap-like action observed.
• Comparison to prior research:
  • Confirms prior reports that jewelweed extracts alone do not reliably prevent PI dermatitis; however, plant mash and soaps show protective effects, aligning with some ethnobotanical and traditional uses.
  • The study aligns with Stibich et al. (2000) in showing that standard soaps tested can offer substantial protection, suggesting that the soap action is a major contributor to dermatitis reduction.
  • Differences with earlier studies (e.g., Guin and Reynolds 1980; Long et al. 1997) may reflect variations in exposure time, preparation, plant material, or participant populations.
• Practical implications:
  • In real-world settings, jewelweed soap and plant mash could serve as practical prophylactics against PI dermatitis, possibly outperforming straight lawsone-containing preparations.
  • Soap and water approaches may be more effective than simple plant extracts for preventing dermatitis after exposure.
  • Historical and ethnomedical practices emphasizing pre-exposure skin treatment with jewelweed material have some scientific backing, particularly when focused on washing action.
• Ethical and methodological considerations:
  • IRB approval was obtained; human subjects were volunteers with informed exposure protocols.
  • The study used a relatively small sample size and two protocols with different N; results should be replicated in larger cohorts for generalization.
• Limitations and avenues for future work:
  • Correlation between lawsone content and protective effect was not supported by the data; more comprehensive analyses of other constituents (e.g., saponins) are warranted.
  • Seasonal variation in lawsone content suggests standardizing harvest time or creating a formulation that accounts for variability.
  • Future studies could investigate the exact molecular interactions between urushiol, lawsone, and saponins, and whether specific saponins drive the observed soap efficacy.

Key numerical references and formulas to remember

• Rash scoring system:
  • Scale: $0, 1, 2, \ldots, 14$ with 0 = no reaction and 14 = continuous covering 91–100% of the area (Table 1 in paper).
• Experimental groups and sample sizes:
  • Protocol 1: $N = 25$; six treatments as listed.
  • Protocol 2: $N = 15$; six treatments as listed.
• Lawsone quantification units (example values):
  • I. capensis mash: $213\ \text{mg/g}$
  • I. capensis roots/aerial parts: $381\ \text{mg/g}$
  • I. balsamina mash (midseason): $744\ \text{mg/g}$
  • I. balsamina mash (end season): $84\ \text{mg/g}$
  • Fresh aqueous infusions: I. capensis $750\ \text{mg/g}$; I. balsamina $745\ \text{mg/g}$
  • Soap preparations: I. capensis soap $113\ \text{mg/g}$; I. balsamina soap $111\ \text{mg/g}$
• Excerpted model of aspect ratios in results:
  • Rash reduction relative to control for mash: ≈ 50% of control (for I. balsamina mash; significant) and for I. capensis mash ≈ 71.5% of control (not always significant depending on protocol).
  • Soap and water comparator performance: soaps ≈ 3.1 on the 0–14 scale; water control ≈ 9.3; significant differences denoted by asterisks in figures.
• Methodology notes to recall:
  • HPLC detection at 278 nm; organic solvent system and column specifics summarized above.
  • Exposure protocol aimed to simulate realistic poison ivy contact times and response.
  • The study emphasizes that the protective effect is likely due to washing and soap action rather than lawsone content per se.

Takeaway and exam-style questions

• What did this study conclude about the role of lawsone in protecting against poison ivy dermatitis?
  • Lawsone content did not correlate with the protective effect; plant mash and soaps provided protection largely independent of lawsone concentration, suggesting other constituents (e.g., saponins) or washing action are key.
• How did jewelweed mash compare to jewelweed soaps and to Dawns dish soap in terms of rash prevention?
  • Jewelweed mash reduced rash development substantially (about 50% of control for some preparations); jewelweed soaps also reduced rash, but not significantly different from other soaps like Dawns; the soap’s efficacy appears related to amphipathic binding/removal of urushiol rather than lawsone content.
• What practical implications do these findings have for real-world use of jewelweed products against PI dermatitis?
  • Soap-and-water approaches using jewelweed extracts may be more effective than purely extract-based preparations; plant mash can be protective, particularly when used as a wash rather than as a topical extract; harvest time and preparation method influence efficacy, underscoring the need for standardized formulations if used clinically.
• Which methodological factors could account for discrepancies between studies on jewelweed’s efficacy?
  • Duration of exposure to urushiol, plant part used, harvest time, preparation method (fresh vs. dried vs. frozen; aqueous vs. alcoholic vs. oil extracts), and the presence of other constituents (saponins) can all influence outcomes.
• What are the ethical considerations when translating ethnobotanical remedies into clinical or consumer products?
  • Ensuring safety (e.g., avoid internal use due to digestive upset or vomiting), standardizing doses and preparations, validating efficacy with robust trials, understanding variability in plant chemistry due to harvest and processing, and ensuring informed consumer guidance about realistic expectations and limitations.

Connections to broader concepts and real-world relevance

• Ethnopharmacology: This study links traditional knowledge with modern experimental validation, highlighting how ethnobotanical practices can inform prophylactic strategies for common allergic conditions.
• Phytochemistry and pharmacognosy: Demonstrates how multiple plant constituents (lawsone, saponins, flavonoids) and physical properties (water content, surfactant activity) influence therapeutic outcomes.
• Public health relevance: Poison ivy dermatitis is a leading cause of allergic contact dermatitis; simple, accessible protective strategies (soap and water, plant-based washes) may reduce morbidity in exposed populations.
• Scientific discourse and replication: Results align with some prior work suggesting limited efficacy of extracts alone, while supporting the practical value of plant-based soaps and mash; variability across studies underscores the need for standardized protocols.

References (selected core sources cited in the study)

• Armstrong, W.P., Epstein, W.L., 1995. Poison oak: more than just scratching the surface. HerbalGram 34, 36–42.
• Guin, J.D., Reynolds, R., 1980. Jewelweed treatment of poison ivy dermatitis. Contact Dermatitis. 6, 287–288.
• Long, D., Ballentine, N.H., Marks Jr., J.G., 1997. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed. Am J Contact Dermatitis 8(3), 150–153.
• Zink, B.J., Otten, E.J., Rosenthal, M., Singal, B., 1991. The effect of jewelweed in preventing poison ivy dermatitis. J Wilderness Med 2, 178–182.
• Oku, H., Ishiguro, K., 2002. Cyclooxygenase-2 inhibitory 1,4-naphthoquinones from Impatiens balsamina L. Biol. Pharm. Bull. 25, 658–660.
• Ishiguro, K., Oku, H., Kato, T., 2000. Testosterone 5α-reductase inhibitor from Impatiens balsamina. Phytotherapy Research 14, 54–56.
• Senchina, D.S., 2005. A critical review of herbal remedies for poison ivy dermatitis. HerbalGram 66, 34–48.
• Stibich, A.S., Yagan, M., Sharma, V., Herndon, B., Montgomery, C., 2000. Cost-effective post-exposure prevention of poison ivy dermatitis. Int J Dermatol 39, 515–518.
• Lipton, R.A., 1958. Comparison of jewelweed and steroid in the treatment of poison ivy contact dermatitis. Annals of Allergy 16, 526– 567.
• Roe (various ethnographic sources on Impatiens uses): Fisher and ethnobotanical notes (as cited in the paper).